Lumizyme®
Lumizyme® (alglucosidase alfa) is an enzyme replacement therapy produced by recombinant DNA technology. It provides a source of alpha-glucosidase an essential enzyme that is deficient or absent in patients with Pompe disease.
For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.
WHAT IT TREATS: |
MANUFACTURER: Sanofi Genzyme |
CLASS: Enzyme Replacement Therapies (ERTs) - lysosomal glycogen-specific enzyme |
PRESCRIBED BY: Neurologists |
HOW ADMINISTERED: IV infusion |
FREQUENCY: Every two weeks |
Length of infusion: About four hours |
FOR MORE INFORMATION: |
